International Journal of Antimicrobial Agents
Volume 20, Issue 4 , Pages 309-310 , October 2002

Extended spectrum β-lactamases of Escherichia coli and Klebsiella pneumoniae in a South Indian tertiary care hospital

References 

  1. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 1995;39:1211–1233
  2. Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 1991;35:1697–1704
  3. Collee JG, Miles RS. Tests for identification of bacteria. In:  Collee JG,  Duguid JP,  Fraser AG,  Marmion BP editor. 13th ed.. Mackie and Mc Cartney practical medical microbiology. 2:Edinburgh: Churchill Livingstone; 1989;p. 141–160
  4. Jarlier V, Nicolas MH, Founier G, Philippon A. Extended spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 1988;10:867–878
  5. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am. J. Clin. Pathol. 1966;45:493–496
  6. Revathi G. Detection of extended spectrum beta-lactamases using E test ESBL strip. Ind. J. Med. Microbiol. 1997;15(2):69–71
  7. Ananthakrishnan AN, Kanungo R, Kumar A, Badrinath S. Detection of extended spectrum beta-lactamase producers among surgical wound infections and burns patients in JIPMER. Ind. J. Med. Microbiol. 2000;18(4):160–165
  8. Subha A, Ananthan S, Alavandi SV. Extended spectrum beta lactamase production and multidrug resistance in Klebsiella species from children under five with intestinal and extraintestinal infections. Ind. J. Med. Res. 2001;113:181–185
  9. Hansotia JB, Agarwal A, Pathak A, Saoji AM. Extended spectrum beta-lactamase mediated resistance to third generation cephalosporins in Klebsiella pneumoniae in Nagpur, central India. Ind. J. Med. Res. 1997;105:158–161
  10. Martinez-Martinez L, Hernandez-Alles S, Alberti S, Tomas J, Benedi V, Jacoby G. In vivo selection of porin deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded spectrum cephalosporins. Antimicrob. Agents Chemother. 1996;40:342–348
  11. Vatopoulos AC, Philippon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of transferable SHV-5 beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. J. Antimicrob. Chemother. 1990;26:635–648
  12. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid mediated AmpC beta-lactamase and the loss of an outer membrane protein. Antimicrob. Agents Chemother. 1997;41:563–569
  13. Paterson DL, Mulazimoglu L, Casellas JM, et al.  Epidemiology of ciprofloxacin resistance and its relationship to extended spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clinic. Infect. Dis. 2000;30:473–478
  14. Martinez-Martinez L, Pascual A, Jacoby GA. Quinolone resistance from a transferable plasmid. Lancet. 1998;351:797–799
  15. Blazquez J, Morosini MI, Negri MC, Baquero F. Selection of naturally occurring extended spectrum TEM beta-lactamase variants by fluctuating beta-lacatam pressure. Antimicrob. Agents Chemother. 2000;44:2182–2184

PII: S0924-8579(02)00178-4

International Journal of Antimicrobial Agents
Volume 20, Issue 4 , Pages 309-310 , October 2002

Article Tools